734464004: Cilastatin sodium (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Hydrolase inhibitor\Peptide hydrolase inhibitor\Cilastatin sodium (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Sulfur and/or sulfur compound\Sulfur compound\Organic sulfur compound\Mercaptan compound (substance)\Organic sulfide compound\Cilastatin sodium (substance)

\Organic compound\Organic sulfur compound\Mercaptan compound (substance)\Organic sulfide compound\Cilastatin sodium (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3506951018 Cilastatin sodium (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3506952013 Cilastatin sodium en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Cilastatin sodium (substance)	Is a	Cilastatin	false	Inferred relationship	Some
Cilastatin sodium (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Peptide hydrolase inhibitor (disposition)	true	Inferred relationship	Some
Cilastatin sodium (substance)	Is a	Peptide hydrolase inhibitor	true	Inferred relationship	Some
Cilastatin sodium (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Cilastatin	true	Inferred relationship	Some
Cilastatin sodium (substance)	Is a	Organic sulfide compound	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
imipenem 500 mg + cilastatin 500 mg pulver til injektionsvæske, suspension, hætteglas	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Cilastatin sodium (substance)	Inferred relationship	Some	1
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Cilastatin sodium (substance)	Inferred relationship	Some	2
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Cilastatin sodium (substance)	Inferred relationship	Some	2
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem 500 milligram/1 vial powder for conventional release suspension for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Cilastatin sodium (substance)	Inferred relationship	Some	2
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Cilastatin sodium (substance)	Inferred relationship	Some	2
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg and relebactam 250 mg powder for solution for infusion vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Cilastatin sodium (substance)	Inferred relationship	Some	3
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg powder for solution for infusion and/or injection vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Cilastatin sodium (substance)	Inferred relationship	Some	2

This concept is not in any reference sets